AstraZeneca predicts faster growth after 'robust' Q1
30th Apr 2021 07:02
(Sharecast News) - AstraZeneca said it expected performance to accelerate as the drugs company reported "robust" revenue growth for the first quarter.
Read moreLondon open: Stocks dip despite tentative moves to reopen international travel
26th Apr 2021 08:38
(Sharecast News) - Stocks are coming under a little bit of selling pressure at the start of trading on Monday as investors monitor the headlines out of Asia concerning the epidemic and its possible impact on economies.
Read moreAstraZeneca upbeat on raft of positive data
26th Apr 2021 07:18
(Sharecast News) - AstraZeneca announced on Monday that the 'MELODY' phase 3 trial for 'nirsevimab' met its primary endpoint of a statistically significant reduction in the incidence of medically-attended lower respiratory tract infections (LRTI) caused by respiratory syncytial virus (RSV) compared to placebo in healthy late preterm and term infants during their first RSV season.
Read moreEU prepares case against AstraZeneca for failed vaccine deliveries
22nd Apr 2021 09:23
(Sharecast News) - The European Commission is working on legal proceedings against AstraZeneca after the drugmaker failed to deliver the Covid-19 vaccines that it had been contracted for with the European Union.
Read moreWednesday broker round-up
21st Apr 2021 12:35
(Sharecast News) - Avast: Canaccord initiates at buy with a target price of 550.0p.
Read moreEU secures further 100m doses of Pfizer-BioNTech vaccine
19th Apr 2021 12:48
(Sharecast News) - The European Union has exercised its option for a further 100m doses of the Pfizer-BioNTech Covid-19 vaccine, the two drug companies confirmed on Monday.
Read moreAustralia reports first blood clot fatality 'linked' to AstraZeneca vaccine
16th Apr 2021 14:37
(Sharecast News) - Australia reported its first fatality from blood-clots related to the AstraZeneca vaccine on Friday.
Read moreAstraZeneca gets US clearance for Alexion acquisition
16th Apr 2021 12:04
(Sharecast News) - AstraZeneca has received US clearance for its proposed acquisition of Alexion Pharmaceuticals.
Read moreDenmark scraps use of AstraZeneca vaccine
14th Apr 2021 15:08
(Sharecast News) - Denmark has stopped using AstraZeneca's vaccine in its Covid-19 inoculation programme because of concerns about cases of rare blood clots.
Read moreWednesday broker round-up
14th Apr 2021 13:07
(Sharecast News) - Gamesys Group: Canaccord downgrades to hold with a target price of 1,878p.
Read moreEU will not renew AstraZeneca and J&J contracts after they expire
14th Apr 2021 08:57
(Sharecast News) - The European Commission will not renew its contracts with AstraZeneca and Johnson & Johnson for the supply of Covid-19 vaccine doses once they expire.
Read moreAstraZeneca's Tagrisso receives Chinese approval
14th Apr 2021 08:31
(Sharecast News) - Drugmaker AstraZeneca said on Wednesday that Tagrisso had been approved in China for the adjuvant treatment of patients with early-stage epidermal growth factor receptor-mutated lung cancer.
Read moreAstraZeneca says Farxiga Covid-19 results not significant
12th Apr 2021 07:03
(Sharecast News) - AstraZeneca said a trial of its Farxiga drug for treating hospitalised Covid-19 patients did not produce statistically significant results.
Read moreWHO chief condemns 'shocking imbalance' in Covid-19 vaccine distribution
9th Apr 2021 15:27
(Sharecast News) - WHO Director-General Tedros Adhanom Ghebreyesus said on Friday that there is a "shocking imbalance" in the distribution of Covid-19 vaccines worldwide and most countries do not have anywhere near enough shots to cover health workers and high risk groups.
Read moreSpain limits AstraZeneca use to people over 60
8th Apr 2021 11:15
(Sharecast News) - Spanish health minister Carolina Darias announced on Wednesday that Spain would restrict use of the AstraZeneca shot to people over the age of 60.
Read more